| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |